Pycior M, Kemmer F W, Berger M
Department of Nutrition and Metabolism, University of Düsseldorf, Germany.
Horm Metab Res Suppl. 1988;18:22-4.
The effects of equipotent subcutaneously injected amounts of biosynthetic human proinsulin and biosynthetic human NPH insulin on blood glucose levels were compared in healthy male volunteers. Mean blood glucose levels decreased to approximately 50 mg/dl after injection of NPH insulin and to 46 mg/dl after injection of proinsulin. This difference reached statistical significance only between 200 and 310 min. after injection. Blood glucose levels rose only marginally thereafter, but increased promptly after ingestion of the standard meal. No differences were observed between the groups. The serum insulin levels reflected the known time insulin curves after NPH injection. The maximum of the proinsulin levels occurred about 4 hours after the injection. Subcutaneous injection of equipotent amounts of biosynthetic human proinsulin and biosynthetic human insulin have similar effects on blood glucose levels.
在健康男性志愿者中比较了皮下注射等效剂量的生物合成人胰岛素原和生物合成人NPH胰岛素对血糖水平的影响。注射NPH胰岛素后平均血糖水平降至约50mg/dl,注射胰岛素原后降至46mg/dl。这种差异仅在注射后200至310分钟之间具有统计学意义。此后血糖水平仅略有上升,但在摄入标准餐后迅速升高。两组之间未观察到差异。血清胰岛素水平反映了注射NPH后已知的胰岛素时间曲线。胰岛素原水平在注射后约4小时达到峰值。皮下注射等效剂量的生物合成人胰岛素原和生物合成人胰岛素对血糖水平有相似的影响。